Entries tagged with “pharmaceutical-industry”
Articles
4 articles found for pharmaceutical-industry:
- Gearing up for the Next Wave of AI in Pharmaceutical Industry – From Cost-based to Value-based models
Artificial intelligence (AI) is reshaping business operations in the health industry. Amid the ever-evolving AI infrastructure, growth in tech-savvy patients and availability of big data, the industry is set to make a transition from using AI for controlling costs to utilizing it for improving patient care. The AI in healthcare market is estimated to reach $6.6Bn in 2021 from $600Mn in 2014, recording a CAGR of 40%; in the five years subsequent to 2021, the market is estimated to grow by more than 10 times.1 In this article, we provide insights on the applications of AI in patient-centric models for improving patient care, from diagnosis to post-treatment care.
- Mass Production to Mass Customization: Pharma Production at Crossroads
The pharmaceutical industry, traditionally based on mass production to meet global medication demands, is now experiencing a transformation due to technological advancements, changing consumer preferences, and the rise of personalized medicine. This shift is challenging the traditional mass production model as the industry moves towards mass customization, aiming to provide tailored drugs for individual patients' requirements.
- CRISPR Therapeutics – Transforming Healthcare
CRISPR technology has been gaining prominence as a realistic treatment option for genetic diseases. Major recent licensing activity is seen from pharmaceutical companies that are also investing in startups in this domain. While technology could revolutionize healthcare, especially for genetic diseases, it has its shortcomings and research is ongoing to address them for wider adoption of CRISPR.
- Global Market Opportunity for Bio-Based Resins
Bio-based resin is being increasingly adopted across industries as the need for sustainability has risen. Bio-based resins, made from partially or wholly plant-derived monomers, offer a sustainable and carbon-positive approach for consumers and manufacturers shifting to a bioeconomy model from highly-priced and depleting fossil fuel ingredients. Government regulations have also boosted their application. Successful commercialization is leading to the growth of bio-based resin throughout the world.
Special Reports
1 special reports found for pharmaceutical-industry:
- Amalgamation of AI in Pharmaceutical Drug Development
Artificial intelligence (AI) is revolutionizing the pharmaceutical industry by helping to accelerate drug discovery, improve manufacturing processes, and personalize patient care. AI-powered tools can analyze vast amounts of data to identify new drug targets, design more effective molecules, and predict the safety and efficacy of potential treatments. As AI continues to mature, it is poised to play an even greater role in the pharmaceutical industry, helping to develop new drugs and improve patient outcomes faster and more efficiently than ever before.